Global Asthma and COPD Drug Market Will Reach USD 26,965.5 Million in 2017: Transparency Market Research

VN:F [1.9.22_1171]
Rating: 4.8/5 (4 votes cast)

Albany NY (March 20, 2013) (CULRAV.ORG) -

According to Transparency Market Research (www.transparencymarketresearch.com) “Asthma and COPD Drug Market – Global Industry Analysis, Market Size, Share, Trends, Growth and Forecasts, 2010 – 2017”, the global asthma and COPD market was worth USD 25,102.3 million in 2010, which is expected to reach USD 26,965.5 million in 2017 with a CAGR of 1.03% over the forecasted period (2010 – 2017). Asthma drug segment dominated the overall asthma and COPD market at USD 14,509.1 million in 2010. The COPD segment was estimated to be worth USD 10,593.2 million in 2010, which is expected to reach USD 12,619.8 million in 2017.

Browse the full report at http://www.transparencymarketresearch.com/asthma-and-copd-market.html

 

In the next five years, the global asthma and COPD drug market is expected to grow slowly, primarily because of expiry of patents of leading drug brands and price erosion in the market. However, by 2017, few novel drugs are expected to enter the asthma and COPD market, which will drive Transparency Market Researchfuture growth. The existing asthma and COPD market is mainly driven by increasing patient population. The other factors that will drive the market include long term use of asthma and COPD drugs, increase in disposable income and improved access to medical care facilities in emerging economies.

asthma market is witnessing intense competition due to the increased entry of inhaled corticosteroids, combinational therapies, and beta-agonists. It is expected that Advair, Symbicort and Singulair would be the leading drugs of the global asthma and COPD market, while Merck, GlaxoSmithKline, and AstraZeneca will continue to be the market leaders till the patents on their drugs expire in the coming years.

 

The opportunities in the asthma and COPD market is huge as many companies are focusing on contract manufacturing outsourcing (CMO) and large players have entered this market with new product development. Increase in awareness about the benefits of timely diagnosis for asthma and COPD and availability of healthcare equipment for the detection of asthma and COPD in rural areas will further boost the market and growth opportunities for market players.

In China, growth in urbanization and change in lifestyle has projected sharp increase in occurrence of asthma in the recent years. The occurrence of asthma symptoms is higher in urban areas as compared to rural areas. Air pollution and smoking are the most important factors which have led to the rapid increase in asthma and COPD patients in China.

The report presents detailed analysis and forecast for the global asthma and COPD market based on the following segmentation:

Product Types

  • Bronchodilators
  • Short Acting Bronchodilators
  • Long Acting Bronchodilators
  • Anticholinergics
  • Anti-Inflammatories
  • Inhaled Corticosteroids
  • Anti-Leukotriene
  • Monoclonal Antibodies
  • Combination Therapies

####

Related Report:

Synthetic Biology Market – Global Industry Analysis, Size, Growth, Share And Forecast, 2012 – 2018

http://www.transparencymarketresearch.com/synthetic-biology-market.html

This report is an effort to identify factors, which will be the driving force for the synthetic biology market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report has segregated the synthetic biology industry in terms of product and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global synthetic biology market and further validated numbers with the key market participants and C-level executives.
This report highlights the industry with the following points:
  • Definition, estimates & forecast of synthetic biology product market from 2010 to 2017
  • Analysis of product segments for synthetic biology product market with historical data and forecast
  • Trends and forecast for four geographic markets, namely North America, Europe, Asia Pacific and the RoW regions based on segments of synthetic biology product market
  • Profiles of major market participants for better understanding of their contributions

This research is specially designed to estimate and analyze the demand and performance of synthetic biology products in a global scenario. The research provides in-depth analysis of synthetic biology product manufacturers, product sales, trend analysis by segments and demand by geography. The report covers all the major product segments of the global synthetic biology market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered.

About Us

 

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Visit: http://www.transparencymarketresearch.com/

VN:F [1.9.22_1171]
Rating: 4.8/5 (4 votes cast)
VN:F [1.9.22_1171]
Rating: +2 (from 2 votes)
Global Asthma and COPD Drug Market Will Reach USD 26,965.5 Million in 2017: Transparency Market Research, 4.8 out of 5 based on 4 ratings


Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. Author: Transparency Market Research@ Transparency Market Research

No comments.

Leave a Reply

You must be logged in to post a comment.